(相关资料图)
花旗将Hims & Hers Health的目标价从16.5美元下调至13.25美元,维持“卖出”评级。(格隆汇)
2026-02-25
2026-02-24
2026-02-21
2026-02-20
2026-02-19
2026-02-18
2026-02-17
2026-02-15
2026-02-13
2026-02-12
2026-02-11
2026-02-08
2026-02-05
2026-02-04
2026-01-30
2026-01-29
2026-01-28
2026-01-26
2026-01-25
2026-01-23
2026-01-22
2026-01-21
2026-01-20